T1	Participants 14 94	smoking cessation among cancer patients enrolled in a smoking cessation program.
T2	Participants 112 127	cancer patients
T3	Participants 454 565	Data from 246 cancer patients participating in a randomized placebo-controlled smoking cessation clinical trial
T4	Participants 1420 1477	Patients with tobacco-related cancers and female patients
T5	Participants 1749 1765	cancer patients.
